IRIS
ROTTOLI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.540
EU - Europa 10.424
AS - Asia 1.664
OC - Oceania 26
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 6
Totale 23.684
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.453
GB - Regno Unito 2.976
IE - Irlanda 1.922
IT - Italia 1.802
CN - Cina 1.320
UA - Ucraina 1.060
SE - Svezia 946
FR - Francia 657
DE - Germania 525
FI - Finlandia 293
VN - Vietnam 95
CA - Canada 83
ES - Italia 79
TR - Turchia 64
IN - India 45
KR - Corea 40
RU - Federazione Russa 39
BE - Belgio 35
AU - Australia 23
NL - Olanda 20
HK - Hong Kong 19
PL - Polonia 17
SG - Singapore 17
IR - Iran 14
EU - Europa 10
JP - Giappone 10
AT - Austria 8
GR - Grecia 7
RO - Romania 7
ID - Indonesia 6
CH - Svizzera 5
PT - Portogallo 5
AZ - Azerbaigian 4
BG - Bulgaria 4
BR - Brasile 4
EE - Estonia 4
LU - Lussemburgo 4
PH - Filippine 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
CL - Cile 3
CO - Colombia 3
KG - Kirghizistan 3
MX - Messico 3
NZ - Nuova Zelanda 3
AR - Argentina 2
CY - Cipro 2
DK - Danimarca 2
KW - Kuwait 2
KZ - Kazakistan 2
LK - Sri Lanka 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
MA - Marocco 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 23.684
Salva come PNG Salva come JPEG
Città #
Southend 2.731
Dublin 1.913
Fairfield 1.801
Chandler 1.159
Houston 874
Jacksonville 862
Ashburn 814
Woodbridge 781
Seattle 641
Wilmington 602
Cambridge 534
Ann Arbor 466
Siena 397
Princeton 367
Beijing 338
Nanjing 273
Menlo Park 151
Helsinki 138
New York 134
Boardman 120
Dearborn 119
Nanchang 117
San Diego 109
Dong Ket 95
San Mateo 86
Florence 78
Shenyang 70
Málaga 69
Shanghai 58
Hebei 55
London 55
Izmir 52
Tianjin 52
Milan 48
Rome 48
Kunming 42
Ottawa 42
Düsseldorf 40
Norwalk 40
Changsha 39
Hangzhou 38
Fremont 36
Jiaxing 35
Brussels 34
Gavirate 30
Jinan 30
Catania 28
Redwood City 27
Guangzhou 26
San Francisco 26
Seongnam 26
Venezia 26
Washington 23
Zhengzhou 22
Lancaster 20
Gießen 19
Ningbo 19
Prato 17
Chicago 16
Changchun 14
Toronto 14
Lanzhou 13
Singapore 13
Arezzo 12
Hefei 12
Los Angeles 12
Edinburgh 11
Frankfurt am Main 11
Phoenix 11
Fuzhou 10
Hong Kong 10
Tappahannock 10
Trieste 10
Miami 9
Montecatini Terme 9
Padova 9
Taizhou 9
Warsaw 9
Bologna 8
Napoli 8
Philadelphia 8
Tokyo 8
Zanjan 8
Canberra 7
Falkenstein 7
Kilburn 7
Livorno 7
Montreal 7
Paris 7
Saronno 7
Vienna 7
Central 6
Codogno 6
Detroit 6
Duncan 6
Figline Valdarno 6
Hounslow 6
Melbourne 6
Moscow 6
Pisa 6
Totale 17.266
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 949
null 398
Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients 382
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis 302
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis 268
Cytokine modulators in the treatment of sarcoidosis 213
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 189
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6 188
Exhaled nitric oxide in interstitial lung diseases 182
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 181
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 177
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 174
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls 173
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 170
Increased Risk of Atherosclerosis in Patients with Sarcoidosis 170
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 169
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 168
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 166
null 165
Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress 160
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 160
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 158
Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model 157
Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity 157
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 157
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 156
Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): A novel disease phenotype? 154
Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis 154
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 153
Quality of life, anxiety and depression in Sarcoidosis 149
Serum chitotriosidase levels in patients with allergic and non-allergic asthma 148
Serum analysis of coagulation factors in IPF and NSIP. 148
null 145
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 144
null 143
The analysis of tryptase in serum of sarcoidosis patients 142
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 142
Tryptase concentrations in bronchoalveolar lavage from patients with chronic eosinophilic pneumonia 142
Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation? 141
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension 141
Phenotypes of organ involvement in sarcoidosis 141
Bronchial stenosis following lung transplant: An innovative approach with a modified endobronchial emphysema valve 136
Oxidative stress in the pathogenesis of diffuse lung diseases: a review 135
Home oxygen therapy: re-thinking the role of devices 135
Sarcoidosis with upper respiratory tract involvement 134
Chromosome 5 inversion in two siblings, one with Klinefelter syndrome and systemic sclerosis, the other with rheumatoid arthritis 134
Asbestos exposure assessment by mineralogical analysis of bronchoalveolar lavage fluid 133
Urgent contralateral pneumonectomy after single lung transplantation for lymphangioleiomyomatosis. 131
Serum amyloid A in patients with idiopathic pulmonary fibrosis 131
Adaptive immune responses in primary cutaneous sarcoidosis 130
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 130
Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. 130
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors 129
Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis 128
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 128
Proteome analysis of bronchoalveolar lavage in individuals from Metsovo, nonoccupationally exposed to asbestos. 128
Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis. 124
Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small cell lung cancer: anlysis of risk factors. 123
Pollen grain viability in Parietaria judaica L. during the long blooming period and correlation with meteorological conditions and allergic diseases 123
Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. 123
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials 123
Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids 122
Calgranulin B (S100A9/MRP14): a Key molecule in idiopathic pulmonary fibrosis? 122
Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation 122
Extracorporeal Photopheresis in Lung Transplantation 122
Bone ultrasonography in glucocorticoid induced osteoporosis 122
null 121
Doubts and certainness in diagnosis of pulmonary embolism in the elderly. 120
Clinical, laboratory and radiological findings in pulmonary fibrosis with and without connective tissue disease 120
Proteomic investigation of pulmonary sarcoidosis 120
P172 Pulmonary Hypertension In Ipf: Utility Of Hrct 119
Assessment of cardiac involvement in sarcoidosis by echocardiography 119
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 119
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1 118
Human Chitotriosidase: a sensitive biomarker of sarcoidosis 118
A difficult case: sarcoidosis with CNS involvement or sarcoidosis associated with multiple sclerosis? 118
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis 117
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? 117
The pharmacological treatment of bronchiectasis 116
Biomarkers in sarcoidosis: The contribution of system biology 116
Idiopathic pulmonary fibrosis. 115
Analysis of trace elements in bronchoalveolar lavage of patients with diffuse lung diseases 115
Serum chitotriosidase activity in sarcoidosis patients 114
Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis 114
New concepts in the pathogenesis of sarcoidosis 114
Concentrations of major elements and mercury in unstimulated human saliva 113
Quetiapine in post-transplant acute mania/bipolar disorder NOS 113
M2 marker expression by alveolar macrophages predicts survival in IPF 113
Proteome analysis of bronchoalveolar lavage in lung diseases. 111
Selection of Candidates for Lung Transplantation: The First Italian Consensus Statement 111
Proteome analysis of bronchoalveolar lavage in pulmonary langerhans cell histiocytosis. 111
Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis 111
BAL Cell Gene Expression is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis 111
Chitotriosidase activity in patients with interstitial lung disesaes 110
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 110
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. 110
Postoperative acute kidney injury in lung transplant recipients 110
Compartimentalizzazione di HCMV: mancata appropiatezza della sola DNAemia nella diagnosi e nella terapia di una polmonite da HCMV post-trapianto polmonare 109
Real-life prospective study on asthma control in Italy: Cross-sectional phase results 109
Pirfenidone in chronic lung allograft dysfunction: a single cohort study 109
Totale 15.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.344 0 0 0 0 0 0 0 0 0 0 677 667
2019/20205.301 647 228 387 819 353 391 450 652 406 460 174 334
2020/20213.905 188 396 145 358 261 489 176 579 376 317 317 303
2021/20222.736 203 393 150 224 132 72 122 125 120 298 318 579
2022/20234.014 299 353 497 594 395 784 78 326 397 97 129 65
2023/20242.562 137 59 234 100 103 775 988 71 17 74 4 0
Totale 24.124